The analysis compared SPRINT participants whose blood pressure drugs were reduced before randomisation with those whose treatment was left unchanged. Under the standard target, only 52.9% were back on their original number of drugs, after a mean of 358 days. Those patients had a 34% higher rate of major cardiovascular events; under the intensive target, restarting was quicker and no excess risk was seen.
Why it is interesting: The reduction in drugs was set by trial protocol rather than chosen by a clinician.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.